Category: Archives

  • The AT&T Hack Just Exposed Millions 

    The AT&T Hack Just Exposed Millions 

    When it comes to cybersecurity threats, we’re still sitting ducks. As we said on June 23, “Cyberattacks are only getting worse. And unfortunately, many government agencies, companies, schools, and millions of people still aren’t prepared for future attacks – meaning we’re all sitting ducks.” At that time, CDK Global, a company that provides U.S. auto…

  • It’s Time to Load up on Uranium Stocks Again

    It’s Time to Load up on Uranium Stocks Again

    With uranium supply still struggling to keep pace with demand, uranium prices could push aggressively higher again.  All thanks to years of underinvesting and mine closures, which put a dent in supply.  Now, according to analysts at Alpine Macro and BCA Research, as highlighted by Investing.com, the supply issue is “further exacerbated by the rapid…

  • These Cannabis Stocks Could See Higher Highs on Florida’s Vote

    These Cannabis Stocks Could See Higher Highs on Florida’s Vote

    As we get closer to November, cannabis stocks could see higher highs. We already know that 88% of Americans want to see legalization, which the current candidates should use to their advantage for votes. We know that Germany just legalized its use, which could set off a domino effect across Europe. We know cannabis will…

  • Top Airline Stocks to Buy on the Dip

    Top Airline Stocks to Buy on the Dip

    Keep an eye on oversold airline stocks. As noted by CNBC, “Summer air travel is expected to soar. The Transportation Security Administration screened a high of 2.99 million individuals on Sunday, June 23 — exceeding a record set just weeks earlier on May 24 — and the TSA is forecasting a record-setting July 4 holiday period. TSA…

  • A Cheaper Way to Trade Obesity Treatments

    A Cheaper Way to Trade Obesity Treatments

    The obesity epidemic is bursting at the seams.   According to the World Health Organization, obesity has tripled since 1975.  More than 1.9 billion adults were overweight, as of 2016, with more than 650 million considered obese. By 2030, about 20% of the global population will be obese, according to the National Centers for Biotechnology Information.   That’s not…

  • This Buy Now, Pay Later Stock Could See 28% Upside

    This Buy Now, Pay Later Stock Could See 28% Upside

    Buy now, pay later (BNPL) stock, Affirm Holdings (AFRM) is seeing signs of life again. All after Goldman Sachs initiated coverage of the stock with a buy rating with a price target of $42 a share. “We view AFRM as the leading provider of modern credit solutions for consumers, with a diverse portfolio of products for…

  • Top Ways to Trade U.S. Infrastructure Issues Heading into Election

    Top Ways to Trade U.S. Infrastructure Issues Heading into Election

    As we get closer to the 2024 presidential election, we’ll hear more about key issues such as infrastructure from both camps. After all, the U.S. is in desperate need of repairs. At the moment, America’s infrastructure is graded a C-, which is an improvement.  Unfortunately, according to the American Society of Civil Engineers (ASCE), “There…

  • This is Why Analysts are Still Bullish on Best Buy

    This is Why Analysts are Still Bullish on Best Buy

    Keep an eye on Best Buy (BBY). After bottoming out at around $70, the stock exploded to a recent high of $91.60. While over-extended to the upside, the run may be far from over. Analysts at UBS just upgraded the stock to a buy rating with a price target of $106.  “Over the next 18…

  • How to Trade the Biotech M&A Boom

    How to Trade the Biotech M&A Boom

    Biotech stocks are breaking higher. All thanks to the return of M&A. Most recently, Bristol Myers agreed to acquire RayzeBio in a $4.1 billion deal, which is a 100% premium to its Friday closing price. “This transaction enhances our increasingly diversified oncology portfolio by bringing a differentiated platform and pipeline, and further strengthens our growth…

  • Viking Therapeutics Could See Substantial Upside this Year

    Viking Therapeutics Could See Substantial Upside this Year

    Keep an eye on rebounding shares of Viking Therapeutics (VKTX). Earlier this year, the company reported that the injectable form of its obesity treatment helped patients lose up to 13.1% of their weight after 13 weeks. Then, the company said the tablet form of its treatment led to a weight loss of about 3.3% after…